- Home
- SIDU vs BOLD Comparison
SIDU vs BOLD Comparison
Compare SIDU & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIDU
- BOLD
- Stock Information
- Founded
- SIDU 2012
- BOLD 2018
- Country
- SIDU United States
- BOLD United States
- Employees
- SIDU N/A
- BOLD N/A
- Industry
- SIDU Telecommunications Equipment
- BOLD
- Sector
- SIDU Telecommunications
- BOLD
- Exchange
- SIDU Nasdaq
- BOLD Nasdaq
- Market Cap
- SIDU 30.0M
- BOLD 24.4M
- IPO Year
- SIDU 2021
- BOLD 2024
- Fundamental
- Price
- SIDU $1.15
- BOLD $1.19
- Analyst Decision
- SIDU
- BOLD Buy
- Analyst Count
- SIDU 0
- BOLD 3
- Target Price
- SIDU N/A
- BOLD $4.00
- AVG Volume (30 Days)
- SIDU 1.6M
- BOLD 105.1K
- Earning Date
- SIDU 08-18-2025
- BOLD 08-11-2025
- Dividend Yield
- SIDU N/A
- BOLD N/A
- EPS Growth
- SIDU N/A
- BOLD N/A
- EPS
- SIDU N/A
- BOLD N/A
- Revenue
- SIDU $3,860,985.00
- BOLD N/A
- Revenue This Year
- SIDU $144.49
- BOLD N/A
- Revenue Next Year
- SIDU N/A
- BOLD N/A
- P/E Ratio
- SIDU N/A
- BOLD N/A
- Revenue Growth
- SIDU N/A
- BOLD N/A
- 52 Week Low
- SIDU $1.08
- BOLD $1.00
- 52 Week High
- SIDU $7.65
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- SIDU 31.00
- BOLD N/A
- Support Level
- SIDU $1.08
- BOLD N/A
- Resistance Level
- SIDU $2.19
- BOLD N/A
- Average True Range (ATR)
- SIDU 0.13
- BOLD 0.00
- MACD
- SIDU -0.10
- BOLD 0.00
- Stochastic Oscillator
- SIDU 6.31
- BOLD 0.00
About SIDU Sidus Space Inc.
Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.